Literature DB >> 627329

Gastric inhibitory polypeptide (GIP) and insulin in obesity: increased response to stimulation and defective feedback control of serum levels.

W Creutzfeldt, R Ebert, B Willms, H Frerichs, J C Brown.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 627329     DOI： 10.1007/bf00429703

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  31 in total

Review 1.  Identification and actions of gastric inhibitory polypeptide.

Authors:  J C Brown; J R Dryburgh; S A Ross; J Dupré
Journal:  Recent Prog Horm Res       Date:  1975

Review 2.  Receptors for insulin, NSILA-s, and growth hormone: applications to disease states in man.

Authors:  J Roth; C R Kahn; M A Lesniak; P Gorden; P De Meyts; K Megyesi; D M Neville; J R Gavin; A H Soll; P Freychet; I D Goldfine; R S Bar; J A Archer
Journal:  Recent Prog Horm Res       Date:  1975

3.  The insulinotropic effect of endogenous gastric inhibitory polypeptide in normal subjects.

Authors:  S E Crockett; S Cataland; J M Falko; E L Mazzaferri
Journal:  J Clin Endocrinol Metab       Date:  1976-06       Impact factor: 5.958

Review 4.  Candidate hormones of the gut. XV. Insulin-releasing factors of the gastrointestinal mucosa (Incretin).

Authors:  M Creutzfeldt
Journal:  Gastroenterology       Date:  1974-10       Impact factor: 22.682

5.  Plasma insulin and growth hormone levels in obesity and diabetes.

Authors:  R S Yalow; S M Glick; J Roth; S A Berson
Journal:  Ann N Y Acad Sci       Date:  1965-10-08       Impact factor: 5.691

6.  Insulin secretion in obesity.

Authors:  R A Kreisberg; B R Boshell; J DiPlacido; R F Roddam
Journal:  N Engl J Med       Date:  1967-02-09       Impact factor: 91.245

7.  Gastrointestinal apudosis in obese hyperglycaemic mice.

Authors:  J M Polak; A G Pearse; L Grimelius; V Marks
Journal:  Virchows Arch B Cell Pathol       Date:  1975-11-07

8.  Gastrin release in postoperative ulcer patients: evidence for release of duodenal gastrin.

Authors:  D H Stern; J H Walsh
Journal:  Gastroenterology       Date:  1973-03       Impact factor: 22.682

9.  Fluctuations in the affinity and concentration of insulin receptors on circulating monocytes of obese patients: effects of starvation, refeeding, and dieting.

Authors:  R S Bar; P Gorden; J Roth; C R Kahn; P De Meyts
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

10.  Gastric inhibitory polypeptide (GIP) stimulation by oral glucose in man.

Authors:  S Cataland; S E Crockett; J C Brown; E L Mazzaferri
Journal:  J Clin Endocrinol Metab       Date:  1974-08       Impact factor: 5.958
View more
  52 in total

Review 1.  Gut hormones and leptin: impact on energy control and changes after bariatric surgery--what the future holds.

Authors:  Konstantinos Michalakis; Carel le Roux
Journal:  Obes Surg       Date:  2012-10       Impact factor: 4.129

2.  Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist (Pro3)GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in ob/ob mice.

Authors:  N Irwin; P L McClean; F P M O'Harte; V A Gault; P Harriott; P R Flatt
Journal:  Diabetologia       Date:  2007-05-08       Impact factor: 10.122

3.  Gut Hormone GIP Induces Inflammation and Insulin Resistance in the Hypothalamus.

Authors:  Yukiko Fu; Kentaro Kaneko; Hsiao-Yun Lin; Qianxing Mo; Yong Xu; Takayoshi Suganami; Peter Ravn; Makoto Fukuda
Journal:  Endocrinology       Date:  2020-09-01       Impact factor: 4.736

4.  RNA-Seq analysis of enteroendocrine cells reveals a role for FABP5 in the control of GIP secretion.

Authors:  Cesar A Sommer; Gustavo Mostoslavsky
Journal:  Mol Endocrinol       Date:  2014-09-30

Review 5.  The incretin concept today.

Authors:  W Creutzfeldt
Journal:  Diabetologia       Date:  1979-02       Impact factor: 10.122

Review 6.  The role of incretins in glucose homeostasis and diabetes treatment.

Authors:  Wook Kim; Josephine M Egan
Journal:  Pharmacol Rev       Date:  2008-12-12       Impact factor: 25.468

7.  Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation?

Authors:  C Niederau; M Berger; W Stremmel; A Starke; G Strohmeyer; R Ebert; E Siegel; W Creutzfeldt
Journal:  Diabetologia       Date:  1984-06       Impact factor: 10.122

8.  Pancreatic islet hormone response to oral glucose in morbidly obese patients.

Authors:  K R Sirinek; T M O'Dorisio; B Howe; A S McFee
Journal:  Ann Surg       Date:  1985-06       Impact factor: 12.969

9.  Gastric inhibitory polypeptide (GIP) hypersecretion in obesity depends on meal size and is not related to hyperinsulinemia.

Authors:  R Ebert; W Creutzfeldt
Journal:  Acta Diabetol Lat       Date:  1989 Jan-Mar

10.  A case-control analysis of common variants in GIP with type 2 diabetes and related biochemical parameters in a South Indian population.

Authors:  Divya Sugunan; Anup K Nair; Harish Kumar; Anilkumar Gopalakrishnapillai
Journal:  BMC Med Genet       Date:  2010-07-30       Impact factor: 2.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.